Applied Genetic Technologies Corporation Gains 29.73%
Fri, Dec 20, 2019 at 06:48 PM
Applied Genetic Technologies Corporation (AGTC:NASDAQ) rocketted at $3.84, representing a gain of 29.7%. The stock got featured on our News Catalysts scanner on Tue 03 Dec 19 at 12:06 PM in the 'ACQUISITION' category. From Fri 29 Nov 19, the stock recorded 50.00% Up Days and 40.00% Green Days
The stock spiked on Fri 27 Sep 19 at $4.61 with a volume of 3M+, and its share price has been moving sideways in recent weeks.
About Applied Genetic Technologies Corporation (AGTC:NASDAQ)
Applied Genetic Technologies Corp is a clinical-stage biotechnology company focused on gene therapy through a nontoxic adeno-associated virus. The company also offers products such as promoters, expression cassettes, and capsids for gene therapy.
Top 10 Gainers:
- DropCar, Inc. (DCAR:NASDAQ), 106.9%
- LAIX Inc. (LAIX:NYSE), 85.51%
- Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 44.67%
- Cortexyme, Inc. (CRTX:NASDAQ), 39.5%
- China Online Education Group (COE:NYSE), 37.36%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 29.73%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 28.57%
- Arbutus Biopharma Corporation (ABUS:NASDAQ), 26.75%
- iBio, Inc. (IBIO:NYSEMKT), 25.58%